IRIS Archives

Information and Referral and Internet Sightings

IRIS@LISTSERV.ICORS.ORG
Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Condense Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Mime-Version:
1.0
Sender:
Information and Referral and Internet Sightings <[log in to unmask]>
Subject:
news byte: Intuniv Extended Release, a Nonstimulant for ADHD
From:
Sylvia Caras <[log in to unmask]>
Date:
Mon, 25 Jun 2007 10:35:19 -0700
Content-Type:
text/plain; charset=us-ascii; format=flowed; x-avg-checked=avg-ok-71D6496E
Reply-To:
[log in to unmask]
Parts/Attachments:
text/plain (12 lines) 
Shire Receives Approvable Letter From FDA for Intuniv Extended 
Release, a Nonstimulant for ADHD

Shire plc announced today that it has received an approvable letter 
from the FDAn for Intuniv extended release tablets , a nonstimulant 
selective alpha-2A-receptor agonist, which has been studied in 
children and adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD).



Powered by LSoft's LISTSERV(R) list management software

ATOM RSS1 RSS2